Breaking News, Financial News

Sanofi-Aventis 3Q09

Pharmaceutical sales were up 6% to $9.3 billion in the quarter and YTD sales rose 4% to $28.5 billion.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi-Aventis 3Q09 3Q Revenues: $10.8 billion (+8%) 3Q Earnings:$3.3 billion (+16%) YTD Revenues: $32.0 billion (+7%) YTD Earnings: $6.7 billion (+20%) Comments: Pharmaceutical sales were up 6% to $9.3 billion in the quarter and YTD sales rose 4% to $28.5 billion. Exchange rates favorably effected results by 2% and 3%, respectively. Lovenox and Lantus sales reached $1.1 billion, up 14% and 22%, respectively. Plavix sales were $968.9 million (+4%). Apidra sales were up 32% in the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters